TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? In fact, from pediatricians to geriatricians, I cannot think of any medical practitioner that does not need to be well informed about the endocannabinoid system and cannabis-based therapeutics. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

The Cannigma

APRIL 8, 2021

The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. So yeah, I spend my time helping physicians and nurses more than I do counting bills and talking to patients. When it comes to cannabis, you can’t even ask your doctor about it, right? Produced by Michael Schaeffer Omer-Man. Music by Desca.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

APRIL 12, 2019

A patient in Alberta spending $600 (~€397) per month on medical cannabis will pay 24.3% ($145.80) in tax. For most Canadian patients, including myself, this means 24.3% CFAMM’s goal is to support medical cannabis patients, improve their outcomes and enable them to obtain fair and safe access to their medication.

Access 45

Access Patients Marijuana Medicine 45

NORML

MARCH 7, 2019

“The Ending Federal Prohibition Act is about acknowledging political, scientific, and economic reality. Sixty-eight percent of registered voters “support the legalization of marijuana,” according to 2018 national polling data compiled by the Center for American Progress.

Legislation 245

Legislation Marijuana Policy Research and Development 245

Cannabis Chronicles

MAY 22, 2019

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”.

Medicine 140

Medicine Research and Development Data Collective 140

SpeedWeed

AUGUST 13, 2021

For us, it was less about using less energy and more about using the energy more efficiently.”. Safety also played a role in Holistic Industries’ decision to convert its indoor facilities to LEDs. The post Texas Cancer Patients, Those With PTSD Gear Up For Medical Cannabis Access appeared first on SpeedWeed.

Access 52

Access Patients Banking Cultivation 52

Veriheal

MAY 30, 2023

A new 2023 study published in BMJ Supportive & Palliative Care suggests that cannabis could be the answer millions of cancer patients have been looking for. According to a 2016 study , about 39.3% of patients experience pain after curative treatment, while 66.4% in cancer patients undergoing anticancer treatment, 50.7%

Medicine 98

Medicine Treatment Patients Data 98

MMJ Recs

NOVEMBER 17, 2023

Medical marijuana (MMJ) has brought about a significant transformation in healthcare and well-being for residents of Maryland. This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales.

CBD 144

CBD Seed-To-Sale Food Access 144

Veriheal

DECEMBER 20, 2022

In particular, sweeping legislation is sparking discussion about the effects of a cannabis “high”—the emotional and physical response experienced by consumers of THC. Furthermore, the data can be utilized to update laws that reflect the truth surrounding cannabis impairment more accurately. operating a motor vehicle).

Research and Development 52

Research and Development Consumption THC Legislation 52

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older. ADDITIONAL INFORMATION.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

NORML

AUGUST 26, 2019

Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business.

Marijuana 206

Marijuana Legalization Programs Oil 206

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

JANUARY 5, 2022

Young and Joyce also question the federal government’s motives, stating, “To be clear, we do not negate the benefit of traditional therapies, but question why the federal government continues to bar access to innovative, proven—and in many cases—safer alternatives.” Young’s Trail of Cannabis Reform.

Legislation 52

Legislation Cannabis Therapy Access 52

Cannabis Law Report

SEPTEMBER 23, 2021

The notice lists five “Things to Know” about the serious health risks of delta-8 THC: Delta-8 THC products have not been evaluated or approved by the FDA for safe use and may be marketed in ways that put the public health at risk. Delta-8 THC products should be kept out of the reach of children and pets. Should be stored away from children.

THC 52

THC Concentrates Pets DEA 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

SpeedWeed

MARCH 6, 2021

Public safety at issue. Proponents of these THC caps—who are often the same politicians who stood against legalization and lost—contend that limiting THC levels will increase public safety. Forcing patients to purchase more. Doing so, Pollara wrote, would effectively force a 50% to 150% tax on patients.

THC 52

THC Patients Law Chronic Pain 52

Cannabis Law Report

APRIL 5, 2022

Metrc will help facilitate Mississippi’s medical cannabis program’s data collection and regulatory oversight through its robust track-and-trace platform. State regulators can also conveniently access this same information, which will be essential in creating a safe and secure marketplace for both patients and providers. “We

Safety 52

Safety Patients Dispensary Compliance 52

Peninsula Alternative Health

JUNE 12, 2023

This landmark legislation, which was developed in response to the approval of Question 4 on the 2022 ballot, brings about significant changes to the cannabis industry in the state. This agency will build upon the existing medical cannabis program regulations and ensure health, safety, and security within the industry.

Legislation 52

Legislation Packaging Edibles Concentrates 52

SpeedWeed

MAY 28, 2021

New Hampshire will now be expanding the pool of patients eligible to receive medical cannabis, thanks to a newly signed bill, HB 89. Under this new law, physicians will be allowed to authorize patients who have moderate or severe insomnia to use medical cannabis. The ratio they used was 30 percent CBD and 1.5 HB 89 and Beyond.

Programs 52

Programs Research and Development Patients Safety 52

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Veriheal

APRIL 11, 2022

You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. We know that the plant has powerful potential medical effects, but it clearly needs more refinement, more research and more data,” stated Groff, who envisions a future where patients can easily access ailment-targeted cannabis meds.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., This data gives us confidence in the use of both the chew and the oils as effective means for delivering CBD to your pet.”.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

SEPTEMBER 22, 2019

Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. PERSONAL RIGHTS.

Cannabis 45

Cannabis Access Patients Legalization 45

Peninsula Alternative Health

JUNE 12, 2023

This landmark legislation, which was developed in response to the approval of Question 4 on the 2022 ballot, brings about significant changes to the cannabis industry in the state. This agency will build upon the existing medical cannabis program regulations and ensure health, safety, and security within the industry.

Legislation 52

Legislation Packaging Edibles Concentrates 52

Veriheal

AUGUST 3, 2021

Under the terms of the legislation, House Bill 1024 will extend cannabis curbside services and indefinitely eradicate the patient cap for actively serving caregivers. In addition to this, patients will be given the opportunity to acquire a 90-day supply of cannabis. Previously, registered patients were limited to a 30-day supply.

Legislation 98

Legislation Patients Supply Chain Dispensary 98

Cannabis Law Report

SEPTEMBER 29, 2021

With more states legalizing cannabis for medical and recreational use, TCI recognizes the critical role that education plays in reducing patient adverse outcomes and ensuring the safe use of cannabis. About The Cannabinoid Institute ?? TCI was founded by Drs.

Cannabinoids 52

Cannabinoids Education Patients Safety 52

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

SEPTEMBER 29, 2022

The Act came into force on October 17, 2018, with two key objectives: To protect the health and safety of Canadians. Prior to the Act’s implementation in 2018, that number sat at 9% according to Health Canada data. Progress towards providing adults with access to strictly regulated, lower-risk, legal cannabis products.

Legislation 59

Legislation Consumption Safety Access 59

SpeedWeed

JULY 25, 2021

Subscribe to our newsletter to get alerts about new posts, local news, and industry insights. At long last the Georgia Access to Medical Marijuana Commission chose six companies that will be allowed to grow, manufacture and sell medical marijuana oil capped at 5% THC. Be the first to know when new content like this is available!

Media 52

Media Data Dispensary Access 52

Veriheal

AUGUST 31, 2020

About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Conclusions.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. Everyone has a story: talking about mental health” podcast launched to eliminate stigma and open up dialogue. On track to report top-line data by end of 2021. LONDON, Aug.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Canna Law Blog

APRIL 13, 2019

These products have not been shown to be safe or effective, and deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. What specific risks should consumers be informed about? Specifically, the agency fears that.

CBD 90

CBD Safety Topical Food 90

Cannabis Law Report

SEPTEMBER 20, 2021

provides Heritage and subsidiary Opticann the benefits of offering patients access to safe, convenient, and effective CB4 products developed on trusted technology platforms. The products leverage pharmaceutical technology to maximize performance and safety. About Heritage Cannabis Holdings Corp.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52